Bonjesta 20 mg / 20 mg, Tablette mit veränderter Wirkstofffreisetzung

7680688670028 CH-68867 Tablette

Associated product:

BONJESTA cpr ret 20mg/20mg 20 pce
Bonjesta 20 mg / 20 mg, Tablette mit veränderter Wirkstofffreisetzung
Bonjesta 20 mg / 20 mg, Tablette mit veränderter Wirkstofffreisetzung
Bonjesta 20 mg / 20 mg, Tablette mit veränderter Wirkstofffreisetzung
1 / 3
google

Article details

Package size
20
Selling units
20
Measure
Tablette(n)
Galenic form
Tablette
Galenic group
unbekannt

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
26/09/2024
Patient information leaflet
Français
26/09/2024
Patient information leaflet
Italien
26/09/2024
Summary of Product Characteristics
Allemand
26/09/2024
Summary of Product Characteristics
Français
26/09/2024
Summary of Product Characteristics
Italien
26/09/2024

Detailed composition

Substance Quantity Type Category
(N/A)
20.0 MG Substance Wirkstoff (Principe actif)
(N/A)
20.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance Konservierungsstoff (Conservateur)
(N/A)
0.007 UG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance FTODK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HBESI
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance FIMDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
0.38 MG Substance HBESI

Reimbursement information

Public price
CHF 47.20
Specialties list
Yes
Generic
No
SL addition date: 01/04/2024

Authorization holder

Exeltis Suisse SA

1228 Plan-Ies-Ouates

Authorization information

Swissmedic authorization number
68867
Drug name
Bonjesta, Tablette mit veränderter Wirkstofffreisetzung
Galenic form
TABWF
ATC Code
R06AA59
Authorization status
Z
Dispensing category
B
First authorization
05/12/2023
Authorization expiration date
04/12/2028
IT Number
01.09.0.
Domain
Human medicine
Field of application
symptomatischen Behandlung von Übelkeit und Erbrechen während der Schwangerschaft bei Frauen, die nicht auf eine konservative Behandlung ansprechen

Package details

Description (FR)
BONJESTA cpr ret 20mg/20mg 20 pce
Description (DE)
BONJESTA Ret Tabl 20mg/20mg 20 Stk
Market launch
05/12/2023
Narcotic (BTM)
No

Other package sizes (5)

None
10 TABL
GTIN: None
Not in V1
None
30 TABL
GTIN: None
Not in V1
None
40 TABL
GTIN: None
Not in V1
None
50 TABL
GTIN: None
Not in V1
None
60 TABL
GTIN: None
Not in V1